您所在的位置: 首页 --> 导师团队 --> 王硕

导师基本信息

  • 姓名:王硕
  • 性别:
  • 民族:汉族
  • 科室:泌尿肿瘤外科
  • 职称:医师
  • 专业:肿瘤学、肿瘤外科学
  • E-MAIL: wangshuoarea@pku.org.cn

学术论文 | 出版专著 | 奖励表彰 | 科研项目 | 招生计划

Comparison of efficacy and prognosis between neoadjuvant chemotherapy and adjuvant chemotherapy in penile cancer patients with regional lymph node metastasis,Front Onco,

SIRT7 expression predicts poor prognosis in upper tract urothelial carcinoma undergoing postoperative platinum-based adjuvant chemotherapy.,Urol Int,

The association of HER-2 expression with clinicopathological characteristics and clinical outcomes in patients with localized prostate cancer after radical prostatectomy,Diagnostics,

Comparing the long-term prognosis and renal function changes of partial nephrectomy (PN) and radical nephrectomy (RN) in T1 stage renal cell carcinoma patients,Transl Androl Urol,

Construction of a 12-gene prognostic risk model and tumor immune microenvironment analysis based on the clear cell renal cell carcinoma model.,Cancer Control,

Unravelling the role of PLK1 in tumorigenesis by revealing the mutational landscape of colorectal and lung cancer with PLK1 mutations.,J Cell Mol Med,

Prognostic and clinicopathological significance of systemic immune inflammation index in upper tract urothelial carcinoma: a meta-analysis of 3911 patients.,Front Oncol,

Mechanistic insights into SIRT7 and EZH2 regulation of cisplatin resistance in bladder cancer cells.,Cell Death Dis,

Pan-Cancer analysis reveals the potential of PLOD1 as a prognostic and immune biomarker for human cancer.,Biomedicines,

Role of inflammatory factors in prediction of Gleason Score and its upgrading in localized prostate cancer patients after radical prostatectomy,Front Oncol,

Combination of hyperthermia and intravesical chemotherapy for the treatment of pT1 stage bladder cancer: a retrospectively clinical study.,Asia Pac J Clin Onco,

The values of HER-2 expression in the non-muscle invasive bladder cancer: a retrospective clinical study.,Front Oncol.,

The values of immune-inflammation index and neutrophil-lymphocyte ratio in the localized prostate cancer and benign prostate hyperplasia: a retrospective clinical study,Front Oncol,

Cancer associated fibroblasts secreted exosomal miR-1290 contributes to prostate cancer cell growth and metastasis via targeting GSK3β,Cell death Discov,

The values of systemic immune-inflammation index and neutrophil-lymphocyte ration in predicting testicular germ cell tumors: a retrospective clinical study,Front Oncol.,

The values of immune-inflammation index and neutrophil-lymphocyte ratio in predicting biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.,Front Oncol,

The association of AR-V7 with resistance to Abiraterone in metastatic castration-resistant prostate cancer.,JOMH,

肿瘤医生说前列腺癌, 副主编, 中国人口出版社, 2023.2

医生喊你来体检, 参编, 中国人口出版社, 2022.5

坎贝尔泌尿外科手册, 副主编, 人民卫生出版社, 2023.8

首都前沿学术成果, 首都前沿学术成果, 第1完成人, 北京市科学技术协会, 2023.3

一项评价瑞维鲁胺联合雄激素剥夺治疗在前列腺癌根治术后高危患者辅助治疗中有效性、安全性的开放、单臂、单中心II期临床研究, 课题负责人, 2025.10.1~2029.12.1, 北京大学肿瘤医院

BRCA基因突变与转移性激素敏感性前列腺癌肿瘤特点、内分泌治疗敏感性及预后的相关性研究, 课题负责人, 2024.1.1~2025.12.1, 北京海淀区卫生健康发展科研培育计划

CTCs AR-V7检测对转移性激素敏感性前列腺癌内分泌治疗敏感性的预测研究, 课题负责人, 2023.1.1~2025.12.1, 北京市医院管理中心

一项评价注射用维迪昔妥单抗(RC48-ADC)治疗经新型内分泌治疗后进展的转移性去势抵抗性前列腺癌(mCRPC)的有效性和安全性的开放、单臂、单中心II期临床研究, 课题负责人, 2023.1.1~2025.12.1, 北京大学肿瘤医院

转移性激素敏感性前列腺癌中HRR突变与内分泌治疗敏感性和患者预后的相关性研究, 课题负责人, 2020.9.1~2026.1.1, 吴阶平基金会临床科研专项基金

PEP-19调控CaMKKII/AR信号通路在前列腺癌中的作用和机制研究, 课题负责人, 2021.3.1~2023.12.1, 北京大学肿瘤医院

研究生招生计划
招生年度 招生专业 学位级别 学位类型 研究方向 选拔方式 操作
2026 肿瘤外科学 硕士 专业学位 临床技能训练与研究 全国统考

社会任职

  • 北京海淀医学会鉴定专家库专家
  • 北京性腺轴疾病防治研究会
  • 北京慢性病防治与健康教育研究会泌尿及男性生殖系统专业委员会
  • 北京医学会鉴定专家库专家;
  • 北京抗癌协会早癌筛查专委会

学习、工作经历

  • 2013.8.1~,北京大学肿瘤医院泌尿外科,主任医师,副教授,硕导;美国杜兰大学博士后;北京大学医学部,硕博连续,博士